Report Overview
Gabapentin enacarbil is an anticonvulsant and analgesic drug of the gabapentinoid class, and a prodrug to gabapentin. It was designed for increased oral bioavailability over gabapentin, and human trials showed it to produce extended release of gabapentin with almost twice the overall bioavailability, especially when taken with a fatty meal. Gabapentin enacarbil has passed human clinical trials for the treatment of restless legs syndrome, and initial results have shown it to be well tolerated and reasonably effective.
This report provides a deep insight into the global Gabapentin Enacarbil market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gabapentin Enacarbil Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gabapentin Enacarbil market in any manner.
Global Gabapentin Enacarbil Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Arbor Pharma
Astellas
GlaxoSmithKline
Glenmark Pharma
Pfizer
Depomed
Teva
Mylan
Novartis
Apotex
Sun Pharmaceutical
Aurobindo Pharma
Intas
Amneal
Marksans Pharma
Alkem
Jiangsu Enhua
Jiangsu Hengrui
Sailike Pharma
Market Segmentation (by Type)
Capsule
Tablet
Market Segmentation (by Application)
Post-Herpetic Neuralgia (PHN)
Restless Legs Syndrome (RLS)
Others
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Gabapentin Enacarbil Market
? Overview of the regional outlook of the Gabapentin Enacarbil Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gabapentin Enacarbil Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Gabapentin Enacarbil
1.2 Key Market Segments
1.2.1 Gabapentin Enacarbil Segment by Type
1.2.2 Gabapentin Enacarbil Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Gabapentin Enacarbil Market Overview
2.1 Global Market Overview
2.1.1 Global Gabapentin Enacarbil Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gabapentin Enacarbil Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Gabapentin Enacarbil Market Competitive Landscape
3.1 Global Gabapentin Enacarbil Sales by Manufacturers (2019-2024)
3.2 Global Gabapentin Enacarbil Revenue Market Share by Manufacturers (2019-2024)
3.3 Gabapentin Enacarbil Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gabapentin Enacarbil Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gabapentin Enacarbil Sales Sites, Area Served, Product Type
3.6 Gabapentin Enacarbil Market Competitive Situation and Trends
3.6.1 Gabapentin Enacarbil Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gabapentin Enacarbil Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Gabapentin Enacarbil Industry Chain Analysis
4.1 Gabapentin Enacarbil Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Gabapentin Enacarbil Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Gabapentin Enacarbil Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gabapentin Enacarbil Sales Market Share by Type (2019-2024)
6.3 Global Gabapentin Enacarbil Market Size Market Share by Type (2019-2024)
6.4 Global Gabapentin Enacarbil Price by Type (2019-2024)
7 Gabapentin Enacarbil Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gabapentin Enacarbil Market Sales by Application (2019-2024)
7.3 Global Gabapentin Enacarbil Market Size (M USD) by Application (2019-2024)
7.4 Global Gabapentin Enacarbil Sales Growth Rate by Application (2019-2024)
8 Gabapentin Enacarbil Market Segmentation by Region
8.1 Global Gabapentin Enacarbil Sales by Region
8.1.1 Global Gabapentin Enacarbil Sales by Region
8.1.2 Global Gabapentin Enacarbil Sales Market Share by Region
8.2 North America
8.2.1 North America Gabapentin Enacarbil Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gabapentin Enacarbil Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gabapentin Enacarbil Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gabapentin Enacarbil Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gabapentin Enacarbil Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Arbor Pharma
9.1.1 Arbor Pharma Gabapentin Enacarbil Basic Information
9.1.2 Arbor Pharma Gabapentin Enacarbil Product Overview
9.1.3 Arbor Pharma Gabapentin Enacarbil Product Market Performance
9.1.4 Arbor Pharma Business Overview
9.1.5 Arbor Pharma Gabapentin Enacarbil SWOT Analysis
9.1.6 Arbor Pharma Recent Developments
9.2 Astellas
9.2.1 Astellas Gabapentin Enacarbil Basic Information
9.2.2 Astellas Gabapentin Enacarbil Product Overview
9.2.3 Astellas Gabapentin Enacarbil Product Market Performance
9.2.4 Astellas Business Overview
9.2.5 Astellas Gabapentin Enacarbil SWOT Analysis
9.2.6 Astellas Recent Developments
9.3 GlaxoSmithKline
9.3.1 GlaxoSmithKline Gabapentin Enacarbil Basic Information
9.3.2 GlaxoSmithKline Gabapentin Enacarbil Product Overview
9.3.3 GlaxoSmithKline Gabapentin Enacarbil Product Market Performance
9.3.4 GlaxoSmithKline Gabapentin Enacarbil SWOT Analysis
9.3.5 GlaxoSmithKline Business Overview
9.3.6 GlaxoSmithKline Recent Developments
9.4 Glenmark Pharma
9.4.1 Glenmark Pharma Gabapentin Enacarbil Basic Information
9.4.2 Glenmark Pharma Gabapentin Enacarbil Product Overview
9.4.3 Glenmark Pharma Gabapentin Enacarbil Product Market Performance
9.4.4 Glenmark Pharma Business Overview
9.4.5 Glenmark Pharma Recent Developments
9.5 Pfizer
9.5.1 Pfizer Gabapentin Enacarbil Basic Information
9.5.2 Pfizer Gabapentin Enacarbil Product Overview
9.5.3 Pfizer Gabapentin Enacarbil Product Market Performance
9.5.4 Pfizer Business Overview
9.5.5 Pfizer Recent Developments
9.6 Depomed
9.6.1 Depomed Gabapentin Enacarbil Basic Information
9.6.2 Depomed Gabapentin Enacarbil Product Overview
9.6.3 Depomed Gabapentin Enacarbil Product Market Performance
9.6.4 Depomed Business Overview
9.6.5 Depomed Recent Developments
9.7 Teva
9.7.1 Teva Gabapentin Enacarbil Basic Information
9.7.2 Teva Gabapentin Enacarbil Product Overview
9.7.3 Teva Gabapentin Enacarbil Product Market Performance
9.7.4 Teva Business Overview
9.7.5 Teva Recent Developments
9.8 Mylan
9.8.1 Mylan Gabapentin Enacarbil Basic Information
9.8.2 Mylan Gabapentin Enacarbil Product Overview
9.8.3 Mylan Gabapentin Enacarbil Product Market Performance
9.8.4 Mylan Business Overview
9.8.5 Mylan Recent Developments
9.9 Novartis
9.9.1 Novartis Gabapentin Enacarbil Basic Information
9.9.2 Novartis Gabapentin Enacarbil Product Overview
9.9.3 Novartis Gabapentin Enacarbil Product Market Performance
9.9.4 Novartis Business Overview
9.9.5 Novartis Recent Developments
9.10 Apotex
9.10.1 Apotex Gabapentin Enacarbil Basic Information
9.10.2 Apotex Gabapentin Enacarbil Product Overview
9.10.3 Apotex Gabapentin Enacarbil Product Market Performance
9.10.4 Apotex Business Overview
9.10.5 Apotex Recent Developments
9.11 Sun Pharmaceutical
9.11.1 Sun Pharmaceutical Gabapentin Enacarbil Basic Information
9.11.2 Sun Pharmaceutical Gabapentin Enacarbil Product Overview
9.11.3 Sun Pharmaceutical Gabapentin Enacarbil Product Market Performance
9.11.4 Sun Pharmaceutical Business Overview
9.11.5 Sun Pharmaceutical Recent Developments
9.12 Aurobindo Pharma
9.12.1 Aurobindo Pharma Gabapentin Enacarbil Basic Information
9.12.2 Aurobindo Pharma Gabapentin Enacarbil Product Overview
9.12.3 Aurobindo Pharma Gabapentin Enacarbil Product Market Performance
9.12.4 Aurobindo Pharma Business Overview
9.12.5 Aurobindo Pharma Recent Developments
9.13 Intas
9.13.1 Intas Gabapentin Enacarbil Basic Information
9.13.2 Intas Gabapentin Enacarbil Product Overview
9.13.3 Intas Gabapentin Enacarbil Product Market Performance
9.13.4 Intas Business Overview
9.13.5 Intas Recent Developments
9.14 Amneal
9.14.1 Amneal Gabapentin Enacarbil Basic Information
9.14.2 Amneal Gabapentin Enacarbil Product Overview
9.14.3 Amneal Gabapentin Enacarbil Product Market Performance
9.14.4 Amneal Business Overview
9.14.5 Amneal Recent Developments
9.15 Marksans Pharma
9.15.1 Marksans Pharma Gabapentin Enacarbil Basic Information
9.15.2 Marksans Pharma Gabapentin Enacarbil Product Overview
9.15.3 Marksans Pharma Gabapentin Enacarbil Product Market Performance
9.15.4 Marksans Pharma Business Overview
9.15.5 Marksans Pharma Recent Developments
9.16 Alkem
9.16.1 Alkem Gabapentin Enacarbil Basic Information
9.16.2 Alkem Gabapentin Enacarbil Product Overview
9.16.3 Alkem Gabapentin Enacarbil Product Market Performance
9.16.4 Alkem Business Overview
9.16.5 Alkem Recent Developments
9.17 Jiangsu Enhua
9.17.1 Jiangsu Enhua Gabapentin Enacarbil Basic Information
9.17.2 Jiangsu Enhua Gabapentin Enacarbil Product Overview
9.17.3 Jiangsu Enhua Gabapentin Enacarbil Product Market Performance
9.17.4 Jiangsu Enhua Business Overview
9.17.5 Jiangsu Enhua Recent Developments
9.18 Jiangsu Hengrui
9.18.1 Jiangsu Hengrui Gabapentin Enacarbil Basic Information
9.18.2 Jiangsu Hengrui Gabapentin Enacarbil Product Overview
9.18.3 Jiangsu Hengrui Gabapentin Enacarbil Product Market Performance
9.18.4 Jiangsu Hengrui Business Overview
9.18.5 Jiangsu Hengrui Recent Developments
9.19 Sailike Pharma
9.19.1 Sailike Pharma Gabapentin Enacarbil Basic Information
9.19.2 Sailike Pharma Gabapentin Enacarbil Product Overview
9.19.3 Sailike Pharma Gabapentin Enacarbil Product Market Performance
9.19.4 Sailike Pharma Business Overview
9.19.5 Sailike Pharma Recent Developments
10 Gabapentin Enacarbil Market Forecast by Region
10.1 Global Gabapentin Enacarbil Market Size Forecast
10.2 Global Gabapentin Enacarbil Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gabapentin Enacarbil Market Size Forecast by Country
10.2.3 Asia Pacific Gabapentin Enacarbil Market Size Forecast by Region
10.2.4 South America Gabapentin Enacarbil Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gabapentin Enacarbil by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Gabapentin Enacarbil Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gabapentin Enacarbil by Type (2025-2030)
11.1.2 Global Gabapentin Enacarbil Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gabapentin Enacarbil by Type (2025-2030)
11.2 Global Gabapentin Enacarbil Market Forecast by Application (2025-2030)
11.2.1 Global Gabapentin Enacarbil Sales (Kilotons) Forecast by Application
11.2.2 Global Gabapentin Enacarbil Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gabapentin Enacarbil Market Size Comparison by Region (M USD)
Table 5. Global Gabapentin Enacarbil Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Gabapentin Enacarbil Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Gabapentin Enacarbil Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Gabapentin Enacarbil Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gabapentin Enacarbil as of 2022)
Table 10. Global Market Gabapentin Enacarbil Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Gabapentin Enacarbil Sales Sites and Area Served
Table 12. Manufacturers Gabapentin Enacarbil Product Type
Table 13. Global Gabapentin Enacarbil Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Gabapentin Enacarbil
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gabapentin Enacarbil Market Challenges
Table 22. Global Gabapentin Enacarbil Sales by Type (Kilotons)
Table 23. Global Gabapentin Enacarbil Market Size by Type (M USD)
Table 24. Global Gabapentin Enacarbil Sales (Kilotons) by Type (2019-2024)
Table 25. Global Gabapentin Enacarbil Sales Market Share by Type (2019-2024)
Table 26. Global Gabapentin Enacarbil Market Size (M USD) by Type (2019-2024)
Table 27. Global Gabapentin Enacarbil Market Size Share by Type (2019-2024)
Table 28. Global Gabapentin Enacarbil Price (USD/Ton) by Type (2019-2024)
Table 29. Global Gabapentin Enacarbil Sales (Kilotons) by Application
Table 30. Global Gabapentin Enacarbil Market Size by Application
Table 31. Global Gabapentin Enacarbil Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Gabapentin Enacarbil Sales Market Share by Application (2019-2024)
Table 33. Global Gabapentin Enacarbil Sales by Application (2019-2024) & (M USD)
Table 34. Global Gabapentin Enacarbil Market Share by Application (2019-2024)
Table 35. Global Gabapentin Enacarbil Sales Growth Rate by Application (2019-2024)
Table 36. Global Gabapentin Enacarbil Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Gabapentin Enacarbil Sales Market Share by Region (2019-2024)
Table 38. North America Gabapentin Enacarbil Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Gabapentin Enacarbil Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Gabapentin Enacarbil Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Gabapentin Enacarbil Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Gabapentin Enacarbil Sales by Region (2019-2024) & (Kilotons)
Table 43. Arbor Pharma Gabapentin Enacarbil Basic Information
Table 44. Arbor Pharma Gabapentin Enacarbil Product Overview
Table 45. Arbor Pharma Gabapentin Enacarbil Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Arbor Pharma Business Overview
Table 47. Arbor Pharma Gabapentin Enacarbil SWOT Analysis
Table 48. Arbor Pharma Recent Developments
Table 49. Astellas Gabapentin Enacarbil Basic Information
Table 50. Astellas Gabapentin Enacarbil Product Overview
Table 51. Astellas Gabapentin Enacarbil Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Astellas Business Overview
Table 53. Astellas Gabapentin Enacarbil SWOT Analysis
Table 54. Astellas Recent Developments
Table 55. GlaxoSmithKline Gabapentin Enacarbil Basic Information
Table 56. GlaxoSmithKline Gabapentin Enacarbil Product Overview
Table 57. GlaxoSmithKline Gabapentin Enacarbil Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. GlaxoSmithKline Gabapentin Enacarbil SWOT Analysis
Table 59. GlaxoSmithKline Business Overview
Table 60. GlaxoSmithKline Recent Developments
Table 61. Glenmark Pharma Gabapentin Enacarbil Basic Information
Table 62. Glenmark Pharma Gabapentin Enacarbil Product Overview
Table 63. Glenmark Pharma Gabapentin Enacarbil Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Glenmark Pharma Business Overview
Table 65. Glenmark Pharma Recent Developments
Table 66. Pfizer Gabapentin Enacarbil Basic Information
Table 67. Pfizer Gabapentin Enacarbil Product Overview
Table 68. Pfizer Gabapentin Enacarbil Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Pfizer Business Overview
Table 70. Pfizer Recent Developments
Table 71. Depomed Gabapentin Enacarbil Basic Information
Table 72. Depomed Gabapentin Enacarbil Product Overview
Table 73. Depomed Gabapentin Enacarbil Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Depomed Business Overview
Table 75. Depomed Recent Developments
Table 76. Teva Gabapentin Enacarbil Basic Information
Table 77. Teva Gabapentin Enacarbil Product Overview
Table 78. Teva Gabapentin Enacarbil Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Teva Business Overview
Table 80. Teva Recent Developments
Table 81. Mylan Gabapentin Enacarbil Basic Information
Table 82. Mylan Gabapentin Enacarbil Product Overview
Table 83. Mylan Gabapentin Enacarbil Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Mylan Business Overview
Table 85. Mylan Recent Developments
Table 86. Novartis Gabapentin Enacarbil Basic Information
Table 87. Novartis Gabapentin Enacarbil Product Overview
Table 88. Novartis Gabapentin Enacarbil Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Novartis Business Overview
Table 90. Novartis Recent Developments
Table 91. Apotex Gabapentin Enacarbil Basic Information
Table 92. Apotex Gabapentin Enacarbil Product Overview
Table 93. Apotex Gabapentin Enacarbil Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Apotex Business Overview
Table 95. Apotex Recent Developments
Table 96. Sun Pharmaceutical Gabapentin Enacarbil Basic Information
Table 97. Sun Pharmaceutical Gabapentin Enacarbil Product Overview
Table 98. Sun Pharmaceutical Gabapentin Enacarbil Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Sun Pharmaceutical Business Overview
Table 100. Sun Pharmaceutical Recent Developments
Table 101. Aurobindo Pharma Gabapentin Enacarbil Basic Information
Table 102. Aurobindo Pharma Gabapentin Enacarbil Product Overview
Table 103. Aurobindo Pharma Gabapentin Enacarbil Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Aurobindo Pharma Business Overview
Table 105. Aurobindo Pharma Recent Developments
Table 106. Intas Gabapentin Enacarbil Basic Information
Table 107. Intas Gabapentin Enacarbil Product Overview
Table 108. Intas Gabapentin Enacarbil Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Intas Business Overview
Table 110. Intas Recent Developments
Table 111. Amneal Gabapentin Enacarbil Basic Information
Table 112. Amneal Gabapentin Enacarbil Product Overview
Table 113. Amneal Gabapentin Enacarbil Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Amneal Business Overview
Table 115. Amneal Recent Developments
Table 116. Marksans Pharma Gabapentin Enacarbil Basic Information
Table 117. Marksans Pharma Gabapentin Enacarbil Product Overview
Table 118. Marksans Pharma Gabapentin Enacarbil Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Marksans Pharma Business Overview
Table 120. Marksans Pharma Recent Developments
Table 121. Alkem Gabapentin Enacarbil Basic Information
Table 122. Alkem Gabapentin Enacarbil Product Overview
Table 123. Alkem Gabapentin Enacarbil Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Alkem Business Overview
Table 125. Alkem Recent Developments
Table 126. Jiangsu Enhua Gabapentin Enacarbil Basic Information
Table 127. Jiangsu Enhua Gabapentin Enacarbil Product Overview
Table 128. Jiangsu Enhua Gabapentin Enacarbil Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Jiangsu Enhua Business Overview
Table 130. Jiangsu Enhua Recent Developments
Table 131. Jiangsu Hengrui Gabapentin Enacarbil Basic Information
Table 132. Jiangsu Hengrui Gabapentin Enacarbil Product Overview
Table 133. Jiangsu Hengrui Gabapentin Enacarbil Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Jiangsu Hengrui Business Overview
Table 135. Jiangsu Hengrui Recent Developments
Table 136. Sailike Pharma Gabapentin Enacarbil Basic Information
Table 137. Sailike Pharma Gabapentin Enacarbil Product Overview
Table 138. Sailike Pharma Gabapentin Enacarbil Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Sailike Pharma Business Overview
Table 140. Sailike Pharma Recent Developments
Table 141. Global Gabapentin Enacarbil Sales Forecast by Region (2025-2030) & (Kilotons)
Table 142. Global Gabapentin Enacarbil Market Size Forecast by Region (2025-2030) & (M USD)
Table 143. North America Gabapentin Enacarbil Sales Forecast by Country (2025-2030) & (Kilotons)
Table 144. North America Gabapentin Enacarbil Market Size Forecast by Country (2025-2030) & (M USD)
Table 145. Europe Gabapentin Enacarbil Sales Forecast by Country (2025-2030) & (Kilotons)
Table 146. Europe Gabapentin Enacarbil Market Size Forecast by Country (2025-2030) & (M USD)
Table 147. Asia Pacific Gabapentin Enacarbil Sales Forecast by Region (2025-2030) & (Kilotons)
Table 148. Asia Pacific Gabapentin Enacarbil Market Size Forecast by Region (2025-2030) & (M USD)
Table 149. South America Gabapentin Enacarbil Sales Forecast by Country (2025-2030) & (Kilotons)
Table 150. South America Gabapentin Enacarbil Market Size Forecast by Country (2025-2030) & (M USD)
Table 151. Middle East and Africa Gabapentin Enacarbil Consumption Forecast by Country (2025-2030) & (Units)
Table 152. Middle East and Africa Gabapentin Enacarbil Market Size Forecast by Country (2025-2030) & (M USD)
Table 153. Global Gabapentin Enacarbil Sales Forecast by Type (2025-2030) & (Kilotons)
Table 154. Global Gabapentin Enacarbil Market Size Forecast by Type (2025-2030) & (M USD)
Table 155. Global Gabapentin Enacarbil Price Forecast by Type (2025-2030) & (USD/Ton)
Table 156. Global Gabapentin Enacarbil Sales (Kilotons) Forecast by Application (2025-2030)
Table 157. Global Gabapentin Enacarbil Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Gabapentin Enacarbil
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gabapentin Enacarbil Market Size (M USD), 2019-2030
Figure 5. Global Gabapentin Enacarbil Market Size (M USD) (2019-2030)
Figure 6. Global Gabapentin Enacarbil Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gabapentin Enacarbil Market Size by Country (M USD)
Figure 11. Gabapentin Enacarbil Sales Share by Manufacturers in 2023
Figure 12. Global Gabapentin Enacarbil Revenue Share by Manufacturers in 2023
Figure 13. Gabapentin Enacarbil Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Gabapentin Enacarbil Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Gabapentin Enacarbil Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Gabapentin Enacarbil Market Share by Type
Figure 18. Sales Market Share of Gabapentin Enacarbil by Type (2019-2024)
Figure 19. Sales Market Share of Gabapentin Enacarbil by Type in 2023
Figure 20. Market Size Share of Gabapentin Enacarbil by Type (2019-2024)
Figure 21. Market Size Market Share of Gabapentin Enacarbil by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gabapentin Enacarbil Market Share by Application
Figure 24. Global Gabapentin Enacarbil Sales Market Share by Application (2019-2024)
Figure 25. Global Gabapentin Enacarbil Sales Market Share by Application in 2023
Figure 26. Global Gabapentin Enacarbil Market Share by Application (2019-2024)
Figure 27. Global Gabapentin Enacarbil Market Share by Application in 2023
Figure 28. Global Gabapentin Enacarbil Sales Growth Rate by Application (2019-2024)
Figure 29. Global Gabapentin Enacarbil Sales Market Share by Region (2019-2024)
Figure 30. North America Gabapentin Enacarbil Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Gabapentin Enacarbil Sales Market Share by Country in 2023
Figure 32. U.S. Gabapentin Enacarbil Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Gabapentin Enacarbil Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Gabapentin Enacarbil Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Gabapentin Enacarbil Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Gabapentin Enacarbil Sales Market Share by Country in 2023
Figure 37. Germany Gabapentin Enacarbil Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Gabapentin Enacarbil Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Gabapentin Enacarbil Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Gabapentin Enacarbil Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Gabapentin Enacarbil Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Gabapentin Enacarbil Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Gabapentin Enacarbil Sales Market Share by Region in 2023
Figure 44. China Gabapentin Enacarbil Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Gabapentin Enacarbil Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Gabapentin Enacarbil Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Gabapentin Enacarbil Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Gabapentin Enacarbil Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Gabapentin Enacarbil Sales and Growth Rate (Kilotons)
Figure 50. South America Gabapentin Enacarbil Sales Market Share by Country in 2023
Figure 51. Brazil Gabapentin Enacarbil Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Gabapentin Enacarbil Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Gabapentin Enacarbil Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Gabapentin Enacarbil Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Gabapentin Enacarbil Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Gabapentin Enacarbil Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Gabapentin Enacarbil Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Gabapentin Enacarbil Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Gabapentin Enacarbil Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Gabapentin Enacarbil Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Gabapentin Enacarbil Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Gabapentin Enacarbil Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Gabapentin Enacarbil Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Gabapentin Enacarbil Market Share Forecast by Type (2025-2030)
Figure 65. Global Gabapentin Enacarbil Sales Forecast by Application (2025-2030)
Figure 66. Global Gabapentin Enacarbil Market Share Forecast by Application (2025-2030)
